Risk and protective factors for COVID-19 morbidity, severity, and mortality
J Zhang, X Dong, G Liu, Y Gao - Clinical reviews in allergy & immunology, 2023 - Springer
The outbreak of the coronavirus disease 2019 (COVID-19), caused by the novel severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become an evolving global …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become an evolving global …
COVID-19 and diabetes mellitus: from pathophysiology to clinical management
Initial studies found increased severity of coronavirus disease 2019 (COVID-19), caused by
infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in patients …
infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in patients …
[HTML][HTML] Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group - Lancet (London, England), 2021 - ncbi.nlm.nih.gov
Background In this study, we aimed to evaluate the effects of tocilizumab in adult patients
admitted to hospital with COVID-19 with both hypoxia and systemic inflammation. Methods …
admitted to hospital with COVID-19 with both hypoxia and systemic inflammation. Methods …
[PDF][PDF] Living guidance for clinical management of COVID-19: living guidance, 23 November 2021
World Health Organization - 2021 - apps.who.int
This guideline is based on the above strategic priorities, and is intended for clinicians
involved in the care of patients with suspected or confirmed COVID-19. It is not meant to …
involved in the care of patients with suspected or confirmed COVID-19. It is not meant to …
Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile
Background Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19)
are occurring in many countries; estimates of vaccine effectiveness are urgently needed to …
are occurring in many countries; estimates of vaccine effectiveness are urgently needed to …
[HTML][HTML] COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics
M Schwarzinger, V Watson, P Arwidson… - The Lancet Public …, 2021 - thelancet.com
Background Opinion polls on vaccination intentions suggest that COVID-19 vaccine
hesitancy is increasing worldwide; however, the usefulness of opinion polls to prepare mass …
hesitancy is increasing worldwide; however, the usefulness of opinion polls to prepare mass …
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
O Abani, A Abbas, F Abbas, M Abbas, S Abbasi… - The Lancet, 2021 - thelancet.com
Background In this study, we aimed to evaluate the effects of tocilizumab in adult patients
admitted to hospital with COVID-19 with both hypoxia and systemic inflammation. Methods …
admitted to hospital with COVID-19 with both hypoxia and systemic inflammation. Methods …
[PDF][PDF] COVID-19 clinical management: living guidance, 25 January 2021
( 2021 World Health Organization - 2021 - apps.who.int
The guidance in this document is based on the above strategic priorities, and is intended for
clinicians involved in the care of patients with suspected or confirmed COVID-19. It is not …
clinicians involved in the care of patients with suspected or confirmed COVID-19. It is not …
Non-pharmaceutical interventions during the COVID-19 pandemic: A review
N Perra - Physics Reports, 2021 - Elsevier
Infectious diseases and human behavior are intertwined. On one side, our movements and
interactions are the engines of transmission. On the other, the unfolding of viruses might …
interactions are the engines of transmission. On the other, the unfolding of viruses might …
Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis
Aim COVID-19 clinical presentation is heterogeneous, ranging from asymptomatic to severe
cases. While there are a number of early publications relating to risk factors for COVID-19 …
cases. While there are a number of early publications relating to risk factors for COVID-19 …